Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Endoprost 125mcg Injection

Prescription Icon
Prescription Required

Marketer

Bharat Serums & Vaccines Ltd

Salt Composition

Carboprost (125mcg)

Overview Endoprost 125mcg Injection

Uterine bleeding following childbirth can be managed with Endoprost 125mcg Injection, a medication that promotes uterine muscle contraction. Administered intramuscularly by a physician in a hospital setting only, self-injection is strictly prohibited. Common side effects, such as nausea, warmth, headache, and shivering, should be reported to your doctor if they become troublesome or severe; mitigating strategies may be available. Dizziness warrants avoidance of driving and activities requiring concentration. Prior to treatment, inform your doctor of any pre-existing heart conditions, hypertension or hypotension, hepatic or renal impairment, and all other medications being used, as interactions may affect efficacy or mechanism of action. This medication is exclusively for postpartum use; it is contraindicated during pregnancy.

Primary Ingredients of Endoprost 125mcg Injection

The information is unavailable.

Uses of Endoprost 125mcg Injection

Hemorrhage postpartum

Major Benefits of Endoprost 125mcg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Endoprost 125mcg Injection:

  • Nausea
  • Vomiting
  • Headache
  • Flushing (sense of warmth in the face, ears, neck and trunk)
  • Hot flashes
  • Diarrhea
  • Chills
  • Placental retention
  • Cough

How to use Endoprost 125mcg Injection:

Administer this medication only as directed by your healthcare provider. Self-medication is strongly discouraged.

How Endoprost 125mcg Injection works:

Uterine muscle contraction is induced by Endoprost 125mcg Injection, thereby aiding in postpartum hemorrhage management.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Endoprost 125mcg Injection may be unsafe; seek medical advice before combining them.

PregnancyPregnancyUNSAFE

Administering Endoprost 125mcg Injection during pregnancy poses a significant risk. Pregnant individuals should consult their physician; research in animal models and human studies has revealed substantial adverse effects on fetal development.

Breast feedingBreast feedingCAUTION

The administration of Endoprost 125mcg Injection to breastfeeding mothers requires careful consideration. Nursing mothers should discontinue breastfeeding throughout their treatment and until the medication is fully cleared from their system.

DrivingDrivingUNSAFE

Administering Endoprost 125mcg Injection might induce adverse reactions that impair driving capabilities. This is because Endoprost 125mcg Injection can potentially lead to loss of consciousness, dizziness, or drowsiness, thus impacting driving safety.

KidneyKidneyCAUTION

Exercise caution when administering Endoprost 125mcg Injection to individuals with impaired renal function; dosage modification may be necessary. Physician consultation is advised. Endoprost 125mcg Injection is contraindicated in patients experiencing active kidney disease.

LiverLiverCAUTION

Individuals with hepatic impairment should use Endoprost 125mcg Injection cautiously; dosage modification may be necessary. Medical advice is recommended. Endoprost 125mcg Injection is contraindicated in patients experiencing active liver disease.

What if you forget to take Endoprost 125mcg Injection :

NA

Facts to Know About Endoprost 125mcg Injection

LabelValue
Type of Compound Prostanoid Analog
Potential for Dependence None.
Type of Medication OBSTETRIC AND GYNECOLOGICAL

FAQs on Endoprost 125mcg Injection

Carboprost 125mcg Injection, administered via injection, is indicated for managing postpartum uterine hemorrhage unresponsive to alternative treatments. This medication is reserved for cases where other interventions prove ineffective. Additionally, it may be employed in the termination of pregnancies ranging from 13 to 20 weeks gestation.
Administered intravenously, this medication is exclusively provided in a hospital or clinic setting by qualified medical personnel. Dosage is determined by the physician, varying according to postpartum hemorrhage severity.
Common adverse reactions can involve vomiting, nausea, diarrhea, facial reddening, and headache. Patients might also experience heightened uterine contractions temporarily. These effects are typically treatable within a hospital environment.
Uterine hemorrhage following childbirth may be managed with Endoprost 125mcg Injection, a medication reserved for cases unresponsive to alternative treatments. This injection may also be employed in medical terminations of pregnancies ranging from thirteen to twenty gestational weeks.
Administered intravenously, this medication is solely provided in a hospital or clinic setting by qualified medical personnel. Dosage is determined by the physician, based on the postpartum hemorrhage severity.
Frequent adverse reactions involve nausea, vomiting, diarrhea, facial flushing, and headache. Patients may also experience heightened uterine contractions; this effect is temporary. These symptoms are treatable within a hospital environment.
Endoprost 125mcg Injectio...
88
MRP 107
17% off